Form 4: Aadi Bioscience CFO Scott Giacobello Reports Stock Transactions

Scott Giacobello, CFO of Aadi Bioscience, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On March 1, 2025, Scott Giacobello, CFO of Aadi Bioscience, had 6,750 restricted stock units (RSUs) vest.
• These RSUs converted into 6,750 shares of common stock.
• On March 3, 2025, Giacobello sold 2,806 shares of common stock at a price of $2.35 per share.
• The sale was executed to cover tax withholding obligations related to the vesting of the RSUs.
• Following these transactions, Giacobello directly owns 23,944 shares of Aadi Bioscience common stock and 20,250 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small number of shares involved.

Key Dates